Open Access. Powered by Scholars. Published by Universities.®
Pharmaceutics and Drug Design Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Engineering (7)
- Chemical Engineering (6)
- Life Sciences (6)
- Other Pharmacy and Pharmaceutical Sciences (6)
- Medicinal and Pharmaceutical Chemistry (5)
-
- Biochemistry (4)
- Biochemistry, Biophysics, and Structural Biology (4)
- Diseases (4)
- Nanotechnology (4)
- Chemicals and Drugs (3)
- Medical Sciences (3)
- Nanomedicine (3)
- Public Health (3)
- Anatomy (2)
- Animals (2)
- Bacterial Infections and Mycoses (2)
- Biology (2)
- Law (2)
- Medical Specialties (2)
- Musculoskeletal System (2)
- Oncology (2)
- Organisms (2)
- Amino Acids, Peptides, and Proteins (1)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Biomedical Engineering and Bioengineering (1)
- Biophysics (1)
- Biotechnology (1)
- Institution
-
- Chapman University (6)
- New Jersey Institute of Technology (6)
- University of Kentucky (5)
- Butler University (2)
- Marshall University (2)
-
- Aga Khan University (1)
- California Polytechnic State University, San Luis Obispo (1)
- Cleveland State University (1)
- Georgetown University Law Center (1)
- Louisiana Tech University (1)
- Purdue University (1)
- The Texas Medical Center Library (1)
- University of Connecticut (1)
- University of Maryland Francis King Carey School of Law (1)
- University of North Florida (1)
- University of Tennessee Health Science Center (1)
- Wayne State University (1)
- Keyword
-
- Dissolution testing (3)
- Calcium phosphate (2)
- Drug delivery (2)
- Enzyme (2)
- Hydroxyapatite (2)
-
- Nanoparticles (2)
- Off-center paddle impeller (2)
- Osteogenesis (2)
- AAA+ superfamily (1)
- Academic -- UNF -- Master of Arts in General Psychology; addiction; NT69L; nicotine; alcohol (1)
- Academic -- UNF -- Psychology; Dissertations (1)
- Acetylcholinesterase (1)
- Air gap membrane distillation (AGMD) (1)
- Alternatives (1)
- Alveolar bone (1)
- Ammonium Sulfate (1)
- Anti-Cocaine (1)
- Aspirin (1)
- Avian Influenza (1)
- BRAF inhibitor (1)
- Bacterial cocaine esterase (1)
- Big data (1)
- Black box (1)
- Blood-brain barrier (1)
- Blood-brain barrier (BBB) (1)
- Brain uptake clearance (1)
- Butyrylcholinesterase (1)
- Ca/Co-HAp (1)
- Canagliflozin (1)
- Cancer therapy (1)
- Publication
-
- Pharmacy Faculty Articles and Research (6)
- Theses (6)
- Theses and Dissertations--Pharmacy (5)
- Pharmaceutical Science and Research (2)
- Scholarship and Professional Work – COPHS (2)
-
- Community Health Sciences (1)
- Dissertations and Theses (Open Access) (1)
- Doctoral Dissertations (1)
- Faculty Scholarship (1)
- Georgetown Law Faculty Publications and Other Works (1)
- Honors Scholar Theses (1)
- Pharmaceutical Sciences Faculty Publications (1)
- STAR Program Research Presentations (1)
- The Summer Undergraduate Research Fellowship (SURF) Symposium (1)
- Theses and Dissertations (ETD) (1)
- UNF Graduate Theses and Dissertations (1)
- Undergraduate Research Posters 2013 (1)
- Publication Type
Articles 31 - 33 of 33
Full-Text Articles in Pharmaceutics and Drug Design
Novel Therapy For Nicotine Addiction In Alcohol Dependent Rats, Bethany Ann Stennett
Novel Therapy For Nicotine Addiction In Alcohol Dependent Rats, Bethany Ann Stennett
UNF Graduate Theses and Dissertations
The co-dependence of nicotine and alcohol addiction occurs at high rates, complicates treatment, and is often associated with significant morbidity and mortality. Treatment options of alcohol and tobacco co-dependence are limited. Currently, there are drugs available for nicotine dependence or alcohol dependence. However, there are no therapeutic drugs available on the market for the co-dependence of nicotine and alcohol. Therefore, and important opportunity of new therapeutic options and drug development has presented itself. NT69L, a non-selective neurotensin (NT) agonist, provides a potential novel therapy for nicotine addiction in alcoholics by interacting with the common neurotransmitter circuits supporting the rewarding process …
Phase Composition Control Of Calcium Phosphate Nanoparticles For Tunable Drug Delivery Kinetics And Treatment Of Osteomyelitis. Part 1: Preparation And Drug Release, Vuk Uskoković, Tejal A. Dasai
Phase Composition Control Of Calcium Phosphate Nanoparticles For Tunable Drug Delivery Kinetics And Treatment Of Osteomyelitis. Part 1: Preparation And Drug Release, Vuk Uskoković, Tejal A. Dasai
Pharmacy Faculty Articles and Research
Developed in this study is a multifunctional material for simultaneous osseoinduction and drug delivery, potentially applicable in the treatment of osteomyelitis. It is composed of agglomerates of nanoparticles of calcium phosphate (CAP) with different monophasic contents. The drug loading capacity and the release kinetics were investigated on two model drug compounds with different chemical structures, sizes and adsorption propensities: bovine serum albumin and fluorescein. Loading of CAP powders with small molecule drugs was achieved by physisorption and desiccation-induced agglomeration of nanoparticulate subunits into microscopic blocks. The material dissolution rate and the drug release rate depended on the nature of the …
Multifunctional Hydroxyapatite And Poly(D,L-Lactide-Co-Glycolide) Nanoparticles For The Local Delivery Of Cholecalciferol, Nenad Ignjatović, Vuk Uskoković, Zorica Ajduković, Dragan Uskoković
Multifunctional Hydroxyapatite And Poly(D,L-Lactide-Co-Glycolide) Nanoparticles For The Local Delivery Of Cholecalciferol, Nenad Ignjatović, Vuk Uskoković, Zorica Ajduković, Dragan Uskoković
Pharmacy Faculty Articles and Research
Cholecalciferol, vitamin D3, plays an important role in bone metabolism by regulating extracellular levels of calcium. Presented here is a study on the effects of the local delivery of cholecalciferol (D3) using nanoparticulate carriers composed of hydroxyapatite (HAp) and poly(D,L-lactide-co-glycolide) (PLGA). Multifunctional nanoparticulate HAp-based powders were prepared for the purpose of: (a) either fast or sustained, local delivery of cholecalciferol, and (b) the secondary, osteoconductive and defect-filling effect of the carrier itself. Two types of HAp-based powders with particles of narrowly dispersed sizes in the nano range were prepared and tested in this study: HAp nanoparticles as direct cholecalciferol delivery …